Global Clean Energy Inc. Algae Reit Update HOUSTON,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
136
Global Clean Energy Inc. Algae Reit Update

HOUSTON, TX --(Marketwired - June 06, 2017) - Global Clean Energy, Inc. ( OTC PINK : GCEI ), has been a publicly traded company since September, 2008 and has seen tremendous challenges and changes in the business of bio-fuels and alternative fuels. The company's Board of Directors from the beginning had as an overriding corporate philosophy to never make decisions that would put the company at risk and that could not be overcome.

The company determined within the last two years that until oil prices rise or conversion costs of feedstock lower dramatically, alternative fuel development which the company has been working on must have as a key component revenue from sources in addition to bio-fuels.

After a tremendous amount of research the company has determined that the number one development is the profitable production of algae indoors in controlled environments in industrial warehouses. The work to date that has been accomplished by numerous companies to increase both production and quality has been amazing. Further, the use of high grade algae will continue to grow to become an estimated $40 billion dollar annual industry, with little of that attributed to bio-fuels. The broad range of use spans for algae include but are not limited to supplements, cosmetics, high grade vitamins, skin care and further efficiencies in the bio-fuels development.

The company determined that profitable cash flow will occur as algae production begins. It was determined that to control quality, increase production and have the best return on investment indoor controlled growing of algae is the way to proceed. Likewise, the optimum facility would be housed in a 50,000 square foot building. It is Global Clean Energy Inc.'s intention to purchase a turnkey plant production site. The company has found numerous facilities in three southern states which meet size, transportation and water requirements. GCE plans completing projected production figures, production goals, sales figures and site acquisition costs in the very near future.

The company will be meeting with its' New York underwriter to determine the REIT pricing. Global Clean Energy plans on becoming the managing general partner and retain 20% equity ownership of the REIT. The final size of the offering will be determined based on the speed at which the operation can be built out.

Updates on other corporate activities will be contained in the company's next news release.

Statements in this release may be regarded, in certain instances, as "forward-looking statements" pursuant to certain sections of the Securities Act 1933 and the Securities Exchange Act 1934, respectively. "Forward-looking statements" are based on expectations, estimates and projections at the time the statements are made, and involve risks and uncertainties, which could cause actual results or events to differ materially from those currently anticipated, including, but not limited to delays, difficulties, changed strategies, or unanticipated factors or circumstances affecting Global Clean Energy, Inc. and its business. There can be no assurance that such forward-looking statements will ever prove to be accurate and readers should not place undue reliance on any such forward-looking statements contained herein. Global Clean Energy Inc. will not republish revised forward-looking statements to reflect events or circumstances after the date hereof to reflect the occurrence of unanticipated events.

GLOBAL CLEAN ENERGY, INC. Investor Relations 713-852-7474 www.globalcleanenergy.net

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Zenas BioPharma Investors Urged to Join Class Action Lawsuit

Updated Category News Views 119

Overview of the Class Action Lawsuit Levi & Korsinsky, LLP is reaching out to investors in Zenas BioPharma, Inc. regarding a crucial class action lawsuit. This lawsuit may greatly impact those who have invested in Zenas BioPharma as it seeks to compensate individuals who have suffered losses due to alleged securities fraud. Understanding the Legal Landscape This class...

Continue Reading
Ayar Labs Raises $155 Million to Transform AI Infrastructure

Updated Category News Views 716

Ayar Labs Secures Significant Funding to Enhance AI Infrastructure Ayar Labs has recently secured $155 million in financing aimed at addressing the critical needs in AI infrastructure. With backing from prominent investors such as AMD Ventures, Intel Capital, and NVIDIA, alongside Advent Global Opportunities and Light Street Capital, this investment elevates the total...

Continue Reading
Transforming the Non-Profit Sector: The Impact Collaborative

Updated Category News Views 159

Impact Collaborative Launches to Transform the Non-Profit Sector Today marks a significant milestone with the launch of the Impact Collaborative (IC), a pioneering initiative aimed at revolutionizing the support provided to under-resourced communities. This innovative approach seeks to disrupt generational poverty while offering much-needed access to mental health and...

Continue Reading
Synovus Financial Corp Declares Quarterly Dividends for Investors

Updated Category News Views 128

Synovus Financial Corp Declares Quarterly Dividends Synovus Financial Corp. (NYSE: SNV) has recently revealed the details of its latest quarterly dividends. The board of directors has approved significant payouts to its shareholders, reinforcing the company’s ongoing commitment to deliver value to its investors. Details of the Declared Dividends The following dividends...

Continue Reading
Walnut Hill Medical Enhances Patient Access Through FDA TAP Program

Updated Category News Views 171

Walnut Hill Medical Partners with FDA in TAP Program Walnut Hill Medical, a prominent healthcare consultancy known for its market access and reimbursement strategies, has been chosen as an advisor to the FDA's Total Product Life Cycle Advisory Program (TAP). This initiative, which originated from the FDA's Center for Devices and Radiological Health (CDRH), aims to improve...

Continue Reading